Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: “Independents need to know they can invest their vote in the Democratic Party,” Carter said Tuesday during his annual report at his post-presidential center and library in Atlanta, where he offered caution about the political consequences should Democrats “move to a very liberal program, like universal health care.” That’s delicate — and, Carter acknowledged, even contradictory — advice coming from the 93-year-old former president, and it underscores the complicated political calculations for Democrats as they prepare for the November midterms and look ahead to the 2020 presidential election. “Rosie and I voted for Bernie Sanders in the past,” Carter noted. He was referring to his wife, Rosalynn, and their support for the Vermont senator, an independent who identifies as a democratic socialist, over establishment favorite Hillary Clinton in the 2016 Democratic presidential primary. At another point, he pointed to California’s environmental policies — limits on carbon emissions, stiffer fuel-efficiency standards — as the model for combating climate change. Still, Carter stressed, Democrats nationally must “appeal to independents” who are souring on the current administration. Trump’s job approval rating, according to Gallup, has dipped to 40 percent, mostly because of declining support among independents. Carter alluded to arguments from self-identified progressives that Democrats will sacrifice votes on the left if they don’t embrace the liberal base: “I don’t think any Democrat is going to vote against a Democratic nominee,” and he insisted that he’s not asking the left to sacrifice its goals, only to see that winning elections is necessary to accomplish any of them. There is some historical irony in Carter’s analysis. He came to the White House in 1976 from the moderate wing of the Democratic Party, and he clashed with party liberals, drawing a spirited primary challenge in 1980 from Massachusetts Sen. Ted Kennedy. Carter prevailed, but he was wounded, abandoned by Kennedy’s most liberal supporters and unable to win over independents who helped deliver a landslide for Republican Ronald Reagan. Carter’s latest handicapping comes near the conclusion of a midterm primary season that has seen Democratic primary voters move the party to the left. In some states and districts, that means nominating full-throated advocates of single-payer health care, a $15 minimum wage and abolishing or at least overhauling the federal Immigration and Customs Enforcement agency. In other races, it means nominees who back more cautious moves to the left, such as background checks before certain gun purchases, a “public option” health insurance plan to compete alongside private insurance policies, step raises for the minimum wage and an immigration overhaul that offers legal status to some immigrants in the country illegally. Carter did not delve into those distinctions, instead offering a sweeping condemnation of his latest successor to remind Democrats of the stakes. He denounced the administration’s latest environmental policy proposal to make it easier for energy companies to release methane gas that contributes to climate change. He singled out Trump’s policy of separating immigrant families at the border, including those seeking asylum. “America is inherently committed to human rights, and I think in the future we will let that prevail,” Carter said, “but for the next two years, I can’t predict the imprisoned children are going to be any better off — unfortunately.” Carter has previously criticized Trump for his repeated falsehoods, and he’s chided Trump for his hardline support for Israel over Palestinians. Yet Carter has found common ground with Trump on other foreign policy fronts, and did so again Tuesday. While avoiding any mention of the special counsel’s investigation into whether Trump’s presidential campaign coordinated with Russia in the 2016 U.S. election, Carter said he has engaged for years with Russian President Vladimir Putin concerning the ongoing Syrian civil war. “I have his email address,” Carter said, adding that he and Putin share the same Russian river as their favorite spot for salmon fishing. That friendship, Carter said, means when Russia and other nations hold multilateral talks about the Syrian conflict, “Quite often they invite the Carter Center. ... They do not invite the U.S. government.” Carter also praised Trump for meeting with North Korean leader Kim Jong Un. Carter repeated his frustrations with the last Democratic president, Barack Obama, for not engaging more directly with the insular Asian nation. Carter said he’s not sure Trump has made real progress yet with North Korea, but he endorsed calls for the U.S. to formally declare an end to the Korean War and normalize relations with Pyongyang. “Let them be part of the community of nations,” he said. “I think that would be enough in itself to bring an end to the nuclear program in North Korea.” ___ Follow Barrow on Twitter at https://twitter.com/BillBarrowAP Claim: Jimmy Carter cautions Democrats not to scare off moderates.
[A]: Former President Jimmy Carter sees little hope for the U.S. to change its human rights and environmental policies as long as Donald Trump is in the White House, but he has a warning for his fellow Democrats looking to oust the current administration: Don’t go too far to the left.


[Q]: Paragraph: The deal would resolve alleged violations of civil environmental statutes, including the Clean Water Act, related to the pollution from a company factory in Waynesboro. It would amount to the largest environmental damage settlement in Virginia history and the eighth largest in the nation, officials said. The money would go to projects including wildlife habitat restoration, water quality enhancement and improvements to recreational areas. “In bringing this settlement to a close, we are finally righting a wrong that has impacted the South River and the South Fork of the Shenandoah River for so many decades,” Democratic Gov. Terry McAuliffe said at a news conference announcing the settlement. Wilmington, Delaware-based Dupont Co. used mercury in its process of making synthetic fiber at the plant between 1929 and 1950, according to the state Department of Environmental Quality. Strict storage and disposal regulations weren’t in place at the time, and some of the mercury seeped into the South River and flowed downstream to the South Fork of the Shenandoah River. DuPont discovered the mercury — which accumulates in fish and is especially dangerous to pregnant or breastfeeding women and young children — in the facility’s soil in 1976, officials say. The pollution impacted over 100 miles of river and thousands of acres of floodplain and riparian habitat, affecting fish, mussels, migratory birds and amphibians, the Department of Justice said in a statement. The pollution also has limited some recreational fishing in Waynesboro, a city of about 20,000 in the Shenandoah Valley. The terms of the settlement are outlined in a proposed consent decree that was filed in federal court in Harrisonburg on Thursday. It is subject to a 45-day public comment period and must be approved by the court. The amount of money proposed is “quite impressive,” but mercury is very persistent in the environment and very difficult to remove, said Dr. Thomas Benzing, a professor of integrated science and technology at James Madison University who works with a team of researchers who have been monitoring the mercury levels since 2001. If the settlement goes forward, DuPont would pay slightly more than $42 million toward projects including streamside plantings and erosion control to improve water quality and fish habitat; mussel propagation and restoration; migratory songbird habitat restoration and protection; and recreational fishing access creation or improvement. The company also will pay for renovations at the Front Royal Fish Hatchery to improve production of warm-water fish such as smallmouth bass, at an estimated cost of up to $10 million. “Every dollar is going to be used to clean up the land, the source issues and the water, to where it would have been” if not for the pollution, said Assistant Attorney General John Cruden of the Justice Department’s Environmental and Natural Resources Division. No one from DuPont — which is awaiting final regulatory approval for its merger with Dow Chemical in a deal to create DowDuPont, a $130 billion conglomerate — spoke at the announcement. But Mike Liberati, South River project director for the DuPont Corporate Remediation Group, said in a statement that DuPont “is committed to a long-term presence in the Waynesboro area and to maintaining transparency with its citizens.” The first phase of remediation, involving part of the riverbank in Waynesboro’s Constitution Park could be complete in February. Soil there containing the highest concentrations of mercury is being excavated and hauled away and replaced by clean topsoil, Liberati said. “It’s going to be a long-term project. It’s not something that’s going to happen overnight,” Benzing said. Claim: DuPont to pay $50M over mercury-contaminated Virginia rivers.
[A]: Chemical giant DuPont will pay more than $50 million but admit no fault under a proposed environmental settlement after releasing toxic mercury for decades that made its way into Shenandoah Valley waterways, state and federal officials announced Thursday.


[Q]: Paragraph: The vaccine, developed by U.S. drugmaker Merck & Co, is already being used under emergency guidelines to try to protect people against the spread of a deadly Ebola outbreak in Democratic Republic of Congo. It protects against the Zaire strain of the Ebola virus - the one that most commonly causes outbreaks. The shot is also being reviewed under a fast-track system by regulators in the United States, with a decision expected in the first quarter of next year. “This vaccine has already saved many lives in the current Ebola outbreak, and the decision by European regulators will help it to eventually save many more,” the WHO’s director-general Tedros Adhanom Ghebreyesus said in a statement. The Congo Ebola outbreak has killed more than 2,100 people since the middle of last year. It is the second-largest Ebola outbreak in history, after a 2013-16 epidemic in West Africa that killed more than 11,300. The Merck vaccine, which the company has now brand-named Ervebo, is likely to get a full marketing license from the European Commission in a few weeks. Roger Perlmutter, president of Merck Research Laboratories, said the company’s priority now was to get regulatory approval of its Ervebo manufacturing site in Germany so that licensed supply of the vaccine “can be used to support global public health preparedness”. Merck’s vaccine is being used in Congo in a so-called “ring vaccination” approach, in which people who may have been in contact with someone newly infected with Ebola are traced and offered the shot to protect them. Charlie Weller, head of vaccines at the Wellcome Trust global heath charity said the Merck shot had already saved “countless lives” in the country. “Having this vaccine available under research conditions has been key in preventing the ongoing outbreak in the DRC spiraling into a repeat of the 2014-16 epidemic, where 11,000 people died,” she told Reuters. Health authorities in Kinshasa said last week they planned to introduce an experimental second Ebola vaccine, developed by  drugmaker Johnson & Johnson, in the country’s eastern provinces in November. The Ebola virus causes hemorrhagic fever and spreads from person to person through direct contact with body fluids. It kills around half of those it infects. There are currently no licensed treatments for the deadly infection, but scientists said in August they were a step closer to being able to cure it after two experimental drugs showed survival rates of as much as 90% in a clinical trial in Congo. Claim:  This is a photograph of a   letter from C. Dennis Packee of Reiman’s Harley-Davidson in Kewanee, Ill.,   to Christopher and Jamie Walters. The letter explains that Reiman’s will   store the Walters’ motorcycles at no charge. It is their way of saying   thank you to military members on deployment.        
[A]:
The world’s first Ebola vaccine was recommended for approval by European drugs regulators on Friday in a move hailed by the World Health Organization (WHO) as a “triumph for public health” that would save many lives.